Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine

  title={Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine},
  author={Rémy Schlichter and Volodymyr K. Rybalchenko and Pierrick Poisbeau and Marc Verleye and Jean-marie Gillardin},

Figures and Tables from this paper

The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain
Effects of etifoxine on ligand binding to GABAA receptors in rodents
Functional modulation of gamma-aminobutyric acidA receptors by etifoxine and allopregnanolone in rodents
It is suggested that etifoxine and allopregnanolone bind to distinct putative recognition sites at or near the chloride channel site, and may have an additive effect by enhancing GABAA inhibitory transmission.
The Non-Benzodiazepine Anxiolytic Drug Etifoxine Causes a Rapid, Receptor-Independent Stimulation of Neurosteroid Biosynthesis
It is demonstrated that etifoxine stimulates neurosteroid production through a membrane receptor-independent mechanism, and the stimulatory effects of et ifoxine and the triakontatetraneuropeptide TTN were additive, indicating that these two compounds act through distinct mechanisms.


Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function.
Because of their abundance in peripheral tissues and in order to distinguish them from the GABAA or central benzodiazepine receptors, this class of benzodi...
Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology
The isolation of a cloned cDNA encoding a new GABAA receptor subunit, termed γ2, which shares approximately 40% sequence identity with α-and β-subunits and whose messenger RNA is prominently localized in neuronal subpopulations throughout the CNS.
Etifoxine: evaluation of its anticonvulsant profile in mice in comparison with sodium valproate, phenytoin and clobazam.
It is concluded that etifoxine has a marked anticonvulsive potential and may be beneficially used in epileptic disorders, especially of the grand mal type.
Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine.
The normalization of CSF ALLO content in depressed patients appears to be sufficient to mediate the anxiolytic and antidysphoric actions of fluoxetine or fluvoxamine via its positive allosteric modulation of GABA type A receptors.
Effect of Zolpidem on Miniature IPSCs and Occupancy of Postsynaptic GABAA Receptors in Central Synapses
The increase of mIPSC amplitude by zolpidem provides evidence that the GABAA receptors are not saturated during miniature synaptic transmission in the recorded cells, and a similar degree of receptor occupancy at room and physiological temperature is estimated.
Modulation of GABAA receptor‐mediated IPSCs by neuroactive steroids in a rat hypothalamo‐hypophyseal coculture model.
The results suggest that, under physiological conditions, allopregnanolone might be a potent modulator of GABAergic synaptic transmission, acting at both pre‐ and postsynaptic sites.
An update on GABAA receptors
Zinc and zolpidem modulate mIPSCs in rat neocortical pyramidal neurons.
Results show that neocortical pyramidal cells have a population of GABAA receptors sensitive to both zinc and zolpidem, which enhanced mIPSCs in a concentration-dependent manner.
Insensitivity to anaesthetic agents conferred by a class of GABAA receptor subunit
A new class of human GABAA receptor subunit (η) that can assemble with α- and β-subunits and confer an insensitivity to the potentiating effects of intravenous anaesthetic agents is described.
δ Subunit Inhibits Neurosteroid Modulation of GABAAReceptors
The results suggest that developmental expression of GABAAreceptor δ subunits may play an important role in determining the region-specific neurosteroid-induced modification of fast inhibitory synaptic function.